Volgen
Sake J. de Vlas
Sake J. de Vlas
Professor, Dept. Public Health, Erasmus MC, Univ. Medical Center Rotterdam, Netherlands
Geverifieerd e-mailadres voor erasmusmc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa
MJ Van der Werf, SJ de Vlas, S Brooker, CWN Looman, NJD Nagelkerke, ...
Acta tropica 86 (2-3), 125-139, 2003
10712003
Underestimation of Schistosoma mansoni prevalences
SJ De Vlas, B Gryseels
Parasitology Today 8 (8), 274-277, 1992
2991992
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic†…
M Brisson, … Bťnard, M Drolet, JA Bogaards, I Baussano, S Všnskš, M Jit, ...
The Lancet Public Health 1 (1), e8-e17, 2016
2562016
Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission
NJD Nagelkerke, P Jha, SJ Vlas, EL Korenromp, S Moses, JF Blanchard, ...
Bulletin of the World Health Organization 80, 89-96, 2002
2352002
Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications
TA Abeku, GJ Van Oortmarssen, G Borsboom, SJ de Vlas, JDF Habbema
Acta tropica 87 (3), 331-340, 2003
2342003
Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence
B Gryseels, A Mbaye, SJ De Vlas, FF Stelma, F Guisse, L Van Lieshout, ...
Tropical medicine & international health 6 (11), 864-873, 2001
2312001
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical†…
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
2202014
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A
MD Spring, JF Cummings, CF Ockenhouse, S Dutta, R Reidler, E Angov, ...
PloS one 4 (4), e5254, 2009
2152009
Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission
AL Ouťdraogo, T Bousema, P Schneider, SJ De Vlas, E Ilboudo-Sanogo, ...
PloS one 4 (12), e8410, 2009
2082009
What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic?
EL Korenromp, MK Sudaryo, SJ de Vlas, RH Gray, NK Sewankambo, ...
International journal of STD & AIDS 13 (2), 91-101, 2002
2042002
Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal
A Danso-Appiah, SJ De Vlas
Trends in parasitology 18 (3), 125-129, 2002
2032002
Environmental factors contributing to the spread of H5N1 avian influenza in mainland China
LQ Fang, SJ de Vlas, S Liang, CWN Looman, P Gong, B Xu, L Yan, ...
PloS one 3 (5), e2268, 2008
1952008
Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa
EL Korenromp, BG Williams, SJ De Vlas, E Gouws, CF Gilks, PD Ghys, ...
Emerging infectious diseases 11 (9), 1410, 2005
1872005
Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa
NJD Nagelkerke, S Moses, SJ de Vlas, RC Bailey
BMC infectious diseases 7 (1), 1-15, 2007
1692007
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa
JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ...
Aids 26, S19-S30, 2012
1642012
Comparison of the Kato-Katz technique, hatching test and indirect hemagglutination assay (IHA) for the diagnosis of Schistosoma japonicum infection in China
JM Yu, SJ De Vlas, QW Jiang, B Gryseels
Parasitology international 56 (1), 45-49, 2007
1532007
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study
JAC Hontelez, MN Lurie, T Bšrnighausen, R Bakker, R Baltussen, ...
PLoS medicine 10 (10), e1001534, 2013
1472013
Spatial analysis of hemorrhagic fever with renal syndrome in China
L Fang, L Yan, S Liang, SJ de Vlas, D Feng, X Han, W Zhao, B Xu, L Bian, ...
BMC infectious diseases 6 (1), 1-10, 2006
1412006
The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study
DCJ Vissers, HACM Voeten, NJD Nagelkerke, JDF Habbema, SJ de Vlas
PloS one 3 (5), e2077, 2008
1402008
The economic impact of SARS in Beijing, China
P Beutels, N Jia, QY Zhou, R Smith, WC Cao, SJ De Vlas
Tropical Medicine & International Health 14, 85-91, 2009
1322009
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20